1.	Phase II Randomized Pilot Study of Sequential Vaccinia-CEA-TRICOM Vaccine, Fowlpox-CEA-TRICOM Vaccine, and Sargramostim (GM-CSF) With Standard Adjuvant Chemotherapy in Women With High-Risk Stage II or III Breast Cancer Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-03-C-0005, NCI-5191, 5191, NCT00052351
2.	Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CDR0000069041, 2840, 1R21CA094523, 2840, DUMC-2840-02-6R1, NCI-1864, 1864, NCT00027534
3.	Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2012-02433, FCCC-01016, CDR0000069093, NCI-1133, 1133, NCT00028496
4.	Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CDR0000437795, DUMC-NCI-7042, NCI-7042, 7042, NCT00128622
5.	Pilot Study of Vaccinia-CEA-TRICOM Vaccine, Fowlpox-CEA-TRICOM Vaccine, Recombinant Fowlpox GM-CSF Vaccine, and Radiotherapy in Patients With Carcinoembryonic Antigen-Positive Solid Tumors Metastatic to the Liver Phase: No phase specified Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-04-C-0167, 6368, NCI-6368, NCT00085241
6.	Pilot Study of Vaccinia-CEA-TRICOM Vaccine, Fowlpox-CEA-TRICOM Vaccine, and Recombinant Fowlpox GM-CSF Vaccine With Paclitaxel, Carboplatin, and Radiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Phase: No phase specified Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-04-C-0252, NCI-6439, 6439, NCT00091039